1 |
Daut, J., Maier-Rudolph, W., von Beckerath, N., Mehrke, G., Gunther, K. and Goedel-Meinen, L. 1990. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247, 1341-1344.
DOI
|
2 |
Duty, S. and Weston, A. H. 1990. Potassium channel openers. Pharmacological effects and future uses. Drugs 40, 785-791.
DOI
|
3 |
Edwards, G., Niederste-Hollenberg, A., Schneider, J., Noack, T., and Weston, A. H. 1994. Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle. Br. J. Pharmacol. 113, 1538-1547.
DOI
|
4 |
Edwards, G. and Weston, A. H. 1990. Structure-activity relationships of channel openers. Trends. Pharmacol. Sci. 11, 417-422.
DOI
|
5 |
Farber, J. L., Kyle, M. E. and Coleman, J. B. 1990. Mechanisms of cell injury by activated oxygen species. Lab. Invest. 62, 670-679.
|
6 |
Foster, C. D., Fujii, K., Kingdon, J. and Brading, A. F. 1989. The effect of cromakalim on the smooth muscle of the guinea-pig urinary bladder. Br. J. Pharmacol. 97, 281-291.
DOI
|
7 |
Gaspar, T., Katakam, P., Snipes, J. A., Kis, B., Domoki, F., Bari, F. and Busija, D. W. 2008. Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J. Neurochem. 105, 1115-1128.
DOI
|
8 |
Gunter, T. E., Gunter, K. K., Sheu, S. S. and Gavin, C. E. 1994 Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol. 267, C313-C339.
DOI
|
9 |
Hagar, H., Ueda, N. and Shah, S. V. 1996. Endonuclease induced DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Kidney Int. 49, 355-361.
DOI
|
10 |
Inoue, I., Nagase, H., Kishi, K. and Higuti, T. 1991. ATP-sensitive channel in the mitochondrial inner membrane. Nature 352, 244-247.
DOI
|
11 |
Murray, M. A., Boyle, J. P. and Small, R. C. 1989. Cromakalim-induced relaxation of guinea-pig isolated trachealis: antagonism by glibenclamide and by phentolamine. Br. J. Pharmacol. 98, 865-874.
DOI
|
12 |
Kersten, J. R., Gross, G. J., Pagel, P. S. and Warltier, D. C. 1998. Activation of adenosine triphosphate-regulated potassium channels: mediation of cellular and organ protection. Anesthesiology 88, 495-513.
DOI
|
13 |
Latorre, R., Castillo, K., Carrasquel-Ursulaez, W., Sepulveda, R. V., Gonzalez-Nilo, F., Gonzalez, C. and Alvarez, O. 2017. Molecular determinants of BK channel functional diversity and functioning. Physiol. Rev. 97, 39-87.
DOI
|
14 |
Lemasters, J. J., Nieminen, A. L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A., Brenner, D. A. and Herman, B. 1998. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196.
DOI
|
15 |
Lyman, G. E. and DeVincenzo, J. P. 1967. Determination of picogram amounts of ATP using the luciferin-luciferase enzyme system. Anal. Biochem. 21, 435-443.
DOI
|
16 |
Morgan, D. M. 1998. Tetrazolium (MTT) assay for cellular viability and activity. Methods. Mol. Biol. 79, 179-183.
|
17 |
Murry, C. E., Jennings, R. B. and Reimer, K. A. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
DOI
|
18 |
Robertson, D. W. and Steinberg, M. I. 1990. Potassium channel modulators: scientific applications and therapeutic promise. J. Med. Chem. 33, 1529-1541.
DOI
|
19 |
Schwartzman, R. A. and Cidlowski, J. A. 1993. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14, 133-151.
|
20 |
Bentzen, B. H., Olesen, S. P., Ronn, L. C. and Grunnet, M. 2014. BK channel activators and their therapeutic perspectives. Front. Physiol. 5, 389.
|
21 |
Bjorkerud, S. and Bondjers, G. 1972. Endothelial integrity and viability in the aorta of the normal rabbit and rat as evaluated with dye exclusion tests and interference contrast microscopy. Atherosclerosis 15, 285-300.
DOI
|
22 |
Clarke, P. G. 1990. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181, 195-213.
|
23 |
Cole, W. C., McPherson, C. D. and Sontag, D. 1991. ATPregulated channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69, 571-581.
DOI
|
24 |
Szewczyk, A. and Marban, E. 1999. Mitochondria: a new target for channel openers? Trends Pharmacol. Sci. 20, 157-161.
DOI
|
25 |
Sparrow, J. R., Hicks, D. and Hamel, C. P. 2010. The retinal pigment epithelium in health and disease. Curr. Mol. Med. 10, 802-823.
DOI
|
26 |
Standen, N. B., Quayle, J. M., Davies, N. W., Brayden, J. E., Huang, Y. and Nelson, M. T. 1989. Hyperpolarizing vasodilators activate ATP-sensitive channels in arterial smooth muscle. Science 245, 177-180.
DOI
|
27 |
Stern, J. and Temple, S. 2015. Retinal pigment epithelial cell proliferation. Exp. Biol. Med (Maywood). 240, 1079-1986.
DOI
|
28 |
Testai, L., Rapposelli, S. and Calderone, V. 2007. Cardiac ATP- sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategy. Cardiovasc. Hematol. Agents. Med. Chem. 5, 79-90.
DOI
|
29 |
Testai, L., Rapposelli, S., Martelli, A., Breschi, M. C. and Calderone, V. 2015. Mitochondrial potassium channels as pharmacological target for cardioprotective drugs. Med. Res. Rev. 35, 520-553.
DOI
|
30 |
Vakifahmetoglu-Norberg, H. Ouchida, A. T. and Norberg, E. 2017. The role of mitochondria in metabolism and cell death. Biochem Biophys. Res. Commun. 482, 426-431.
DOI
|
31 |
Wimmers, S., Karl, M. O. and Strauss, O. 2007. Ion channels in the RPE. Prog. Retin. Eye. Res. 26, 263-301.
DOI
|